Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorKTH Biopharma
About this trial
Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.
Eligibility criteria
Qualifiers
18 years of age or older.
Able to read and understand the Patient Information Sheet and the Informed Consent form.
Acceptance in the participation of the essay and signature of the Informed Consent form.
Diagnosis of genital and anal warts with clear clinical manifestations.
Disqualifiers
Concomitant sexually transmitted infections such as gonorrhea, syphilis, genital herpes, etc., that have not been cured.
Ulceration or suspected malignant transformation of the lesions.
Local infections.
Pregnant women.
Trial design
Treatments tested in this trial
- Geniwa gel
- Placebo gel
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov